Comparative study of imidocarb, buparvarvaquone & diminazinein treatment of draught horses affected with equine babesiosis
Iraqi Journal of Veterinary Sciences,
Volume 20, Issue 1, Pages 103-112
AbstractA 30 drought male horses (4-12) years old infected with equine babesiosis were used in this study. The animals were divided randomly into three groups, 10 animals for each. First group was treated with Imidocarb dipropionate
intramusculary at a dose rate of 4 mg/kg B.W. repeated after 48 h., the second group treated with Diminazine aceturate intramusculary at dose rate of 3.5 mg/kg B.W. repeated after 48 h., and the third group treated with Buparvaquone intramusculary at dose rate of 6 mg/kg B. W. repeated after 48 h. The main parameters used were clinical signs, hematological changes, percentage of parasitemia and changes of some biochemical values pre and post treatment for evaluation of therapeutic efficacy against natural infection with equine babesiosis.
Results indicated that imidocarb at dose rate of 4 mg/kg B. W. intramusculary repeated after 48 h., is more effective in the treatment of equine babesiosis in comparison with diminazine and buparvaquone as well as buparvaquone used for the first time give good result but does not cause complete elimination of babesia bodies.
- Article View: 238
- PDF Download: 31